Pages that link to "Q41621644"
Jump to navigation
Jump to search
The following pages link to Estrogen and the Treatment of Alzheimer’s Disease (Q41621644):
Displaying 13 items.
- Postmenopausal hormone therapy and cognition (Q27008086) (← links)
- Hormone replacement therapy and Alzheimer's disease (Q33642682) (← links)
- Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis (Q33857720) (← links)
- The role of serotonin in hot flushes (Q34076822) (← links)
- Aromatase and its inhibition in behaviour, obsessive compulsive disorder and parkinsonism (Q34176962) (← links)
- Potential novel targets for Alzheimer pharmacotherapy: I. Secretases (Q34703558) (← links)
- Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases (Q34784469) (← links)
- Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. (Q35156240) (← links)
- Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels (Q38448466) (← links)
- Cortical cholinergic denervation elicits vascular A beta deposition. (Q42488273) (← links)
- Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease (Q43654279) (← links)
- Can testosterone replacement decrease the memory problem of old age? (Q44406385) (← links)
- Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study (Q51983422) (← links)